Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma
Clinical trial NCT02502370 · UNKNOWN
Trial details
- NCT number
- NCT02502370
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Primary completion
- 2023-09-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.